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Abstract
A Geant4-based Monte Carlo model for Heavy-Ion Therapy (MCHIT)
is used to study radiation fields of 1H, 4He, 7Li and 12C beams with
similar ranges (∼160-180 mm) in water. Microdosimetry spectra are sim-
ulated for wall-less and walled Tissue Equivalent Proportional Counters
(TEPCs) placed outside or inside a phantom, as in experiments performed,
respectively, at NIRS, Japan and GSI, Germany. The impact of fragmen-
tation reactions on microdosimetry spectra is investigated for 4He, 7Li
and 12C, and contributions from nuclear fragments of different charge are
evaluated for various TEPC positions in the phantom. The microdosime-
try spectra measured on the beam axis are well described by MCHIT,
in particular, in the vicinity of the Bragg peak. However, the simulated
spectra for the walled TEPC far from the beam axis are underestimated.
Relative Biological Effectiveness (RBE) of the considered beams is esti-
mated using a modified microdosimetric-kinetic model. Calculations show
a similar rise of the RBE up to 2.2–2.9 close to the Bragg peak for helium,
lithium and carbon beams compared to the modest values of 1–1.2 at the
plateau region. Our results suggest that helium and lithium beams are
also promising options for cancer therapy.
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1 Introduction
Presently proton and 12C beams are successfully used for cancer treatment [1,
2, 3, 4]. Other projectiles, e.g. 4He and 7Li, may differ in their biological action
from 12C nuclei, but still have beam divergence similar to 12C, and thus can
be considered as new treatment options [5]. Beams of protons, helium, lithium,
beryllium, carbon, and neon nuclei were recently compared [6] from the point of
view of their advantage to spare healthy tissues with respect to radiobiological
parameters (α/β ratio) of normal and target tissues. Other authors [5, 7] studied
the depth-dose and linear energy transfer (LET) distributions of protons, 4He,
7Li and 12C in water using the Monte Carlo codes SHIELD-HIT and FLUKA,
respectively.
In view of possible applications of nuclei other than carbon in cancer ther-
apy, the quality of radiation fields created by such projectiles has to be studied.
For this purpose we have used our Monte Carlo model for Heavy-Ion Therapy
(MCHIT) [8, 9, 10, 11, 12] based on the Geant4 toolkit [13, 14]. In a recent publi-
cation [10] we have compared the depth-dose distributions for various projectiles
propagating in water. These calculations took into account the fragmentation
of projectile nuclei in collisions with nuclei of the medium. The calculated dose
profiles were compared with experimental data where available. In particular,
the depth-dose profiles for 3He nuclei in water were studied along with the
distributions of positron-emitting nuclei produced by these projectiles [9].
While the capabilities of the Geant4 toolkit to model propagation of pro-
tons and carbon nuclei in tissue-like media were already demonstrated in several
publications, see e.g. [15, 16] and [17], much less attention was paid to simula-
tions with other projectiles, e.g. 4He and 7Li. One may expect that due to a
reduced total reaction cross section of these light projectiles, the importance of
fragmentation reactions on the corresponding dose distribution will be reduced
with respect to 12C. On the other hand one can note, that while boron or beryl-
lium nuclei are frequently produced by 12C with their Z2 close to the projectile
nucleus, 4He usually fragments into a proton, a neutron and a deuteron resulting
in a rapid drop of Z2. This indicates that in addition to the known reduction of
the total fragmentation cross section with the decrease of the projectile mass,
the composition of secondary fragments has also to be taken into account. In
turn, this will lead to different biological properties of such beams.
As demonstrated recently, MCHIT describes well microdosimetry spectra for
neutron and carbon-ion beams [18]. In this work we present Monte Carlo calcu-
lations of microdosimetry distributions for proton, 4He, 7Li and 12C beams in
water and compare results with experimental data. The obtained microdosime-
try spectra are used to estimate the Relative Biological Effectiveness (RBE) of
these nuclei both on the beam axis and away from it. Differences in the physical
and biological properties of these therapeutic beams are discussed.
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2 Materials and Methods
2.1 Microdosimetric Measurements
Patterns of energy deposition in tissue by ionizing particles at the micrometer
scale can be measured by Tissue Equivalent Proportional Counters (TEPC). The
amount of energy delivered to the TEPC sensitive volume by particles traversing
the detector fluctuates due to the stochastic nature of particle transport in
media [19]. Therefore, the lineal energy y = ǫ/l¯, where ǫ is the deposited energy
in a given event and l¯ is the mean chord length of the sensitive volume, changes
from one event to another and a probability density f(y) can be measured. This
probability density is usually characterized by the frequency-mean lineal energy,
y¯f , and dose-mean lineal energy, y¯d, defined [19] as
y¯f =
∫
∞
0
yf(y)dy , (1)
y¯d =
1
y¯f
∫
∞
0
y2f(y)dy =
∫
∞
0
yd(y)dy. (2)
Here d(y) ≡ yf(y)/y¯f is introduced as the dose probability density. The
saturation-corrected dose-mean lineal energy, y∗, defined [19] as:
y∗ =
y2
0
∫
∞
0
(
1− exp
(
−y2/y2
0
))
f(y)dy∫
∞
0
yf(y)dy
, (3)
is introduced to account for the saturation of biological effects induced by high-
LET radiation. The saturation parameter y0 = 150 keV/µm [20] is used in our
study.
2.1.1 Microdosimetry of 1H and 4He beams
Microdosimetry measurements for 160 MeV proton and 150A MeV helium
beams were performed at the Heavy Ion Medical Accelerator in Chiba (HIMAC)
of the National Institute of Radiological Science (NIRS), Japan [21]. The Bragg
peaks in water for such proton and helium projectiles are located at the depth
of ∼ 175.6 and ∼ 158 mm, respectively. A wall-less TEPC simulating a tissue
volume of 0.72 µm in diameter was employed along with a range shifter for
energy degradation. The geometry of the wall-less TEPC including the anode,
cathode, insulators, field tubes and beam window components, is implemented
in MCHIT, as illustrated in Fig. 1. The helical geometry of the cathode is
simulated by small G4Torus segments displaced along and rotated around the
anode wire. A total of 360 torus segments per pitch is used. The range shifter
is simulated as a water layer in front of the detector device. Microdosimetry
spectra at various beam energies were measured at HIMAC by changing the
thickness of the range shifter. The uncertainties in the water equivalent thick-
ness of the range shifter and beam elements in the experimental set-up were not
3
Figure 1: Inner geometry of a wall-less TEPC implemented in MCHIT.
reported. Taking into account that the precise dimension and material prop-
erties of the range shifter were not reported, and also that the calculation of
water-equivalent thickness is influenced by uncertainties in the stopping power
of ions, in our simulations we decided to adjust the thickness of the range shifter
in order to reproduce the position of the main peak in microdosimetry spectra
which is associated with primary beam particles traversing the detector. The
water equivalent thickness used in the simulations are smaller than the esti-
mated value for the experimental set-up by about 3% and 0.8% for proton and
helium beams, respectively. A total of 4 × 107 events were simulated for each
microdosimetry spectrum. The experimental data were reported as yf(y)/y¯f
distributions.
2.1.2 Microdosimetry of 7Li and 12C beams
Microdosimetry spectra for 185A MeV 7Li and 300A MeV 12C beams were
measured at GSI, Germany [22] at several positions inside a water phantom.
A compact walled TEPC was employed to measure microdosimetry spectra for
a tissue equivalent volume of 2.7 µm in diameter. The total water equivalent
thickness of the PMMA wall of the water phantom and beam-line elements
used in experiment [22] amounts to 25.1 mm. Similar to the calculations for 1H
and 4He beams described above, the TEPC positions were adjusted in order to
reproduce the position of the main peak in the spectra when the TEPCs were
placed on the axis in the vicinity of the Bragg peak of 7Li and 12C beams. The
shift of the TEPC for the carbon beam (2 mm deeper position which corresponds
to 1% of the range of carbon ion) was discussed elsewhere [18]. As for 7Li beam,
the microdosimetry spectrum measured for the TEPC located at the Bragg peak
could be only reproduced by calculations if the TEPC is further shifted to deeper
position by 6.7 mm. One must notice that our simulations have shown that the
range in the water phantom for 185A MeV 7Li beam is 5 mm deeper than the
one for the 300AMeV 12C beam while it was reported that the specific energies
for the carbon and lithium beams in the experimental set-up were chosen such
that the residual range in the water phantom is the same for both ions [22].
The simulated geometry of the walled TEPC, see Fig. 2, includes its external
aluminium cap, a 1.27 mm thick wall made of Shonka A-150 tissue-equivalent
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plastic and an inner spherical gas cavity. The cathode and anode elements in
the detection region were not simulated. A total of 107 histories of primary
ions and all their secondary particles were simulated for each microdosimetry
spectrum. Each walled TEPC detector placed far from the beam axis was
represented in simulations by a number of virtual TEPCs placed on a ring at
the same depth [18]. Due to this special arrangement of virtual TEPC detectors,
the counting rate of events per primary track is significantly increased in each
physical TEPC. The experimental data were reported as yd(y) distributions
normalized to the number of incoming primary ions.
Figure 2: Geometry of a walled TEPC implemented in MCHIT with tracks
of secondary particles produced in one event for a 12C nucleus (blue track)
crossing the TEPC wall. Red and green tracks represent secondary electrons
and photons, respectively. The external aluminium cap is not shown.
2.2 Monte Carlo modelling by MCHIT
Microdosimetry spectra and related variables are calculated by the Monte Carlo
method using MCHIT. This code is a Geant4 application based on the version
9.5 with patch 02 of this toolkit. Description of the physics models included in
the Geant4 toolkit is given elsewhere [23]. A set of models which are relevant to a
particular problem should be activated by the application developer. In MCHIT
we make use of the so-called predefined physics lists along with customized
physics lists. The predefined physics lists are provided by Geant4 developers
and distributed along with Geant4. Separate physics lists for electromagnetic
and hadronic physics are kept for convenience. More details on the physics
models used in MCHIT can be found elsewhere [18].
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2.2.1 Electromagnetic physics
Three different predefined physics list for electromagnetic processes are em-
ployed in the following calculations, namely G4EmStd (which uses the “Stan-
dard Electromagnetic Physics Option 3”), G4EmPen (which uses the Penelope
models for low energy processes) and G4DNA (which uses the track structure
models known as G4DNA models). The involved physics models simulate the
energy loss and straggling of primary and secondary charged particles due to in-
teraction with atomic electrons. G4EmStd and G4EmPen are based on continu-
ous slowing-down approximation and algorithms of multiple Coulomb scattering
of charged particles on atomic nuclei. G4DNA explicitly simulate each single
electromagnetic interaction. These physics lists differ in the capability of models
to produce and transport low-energy δ-electrons. The low-energy thresholds for
production of δ-electrons are 990 eV for G4EmStd and 100 eV for G4EmPen,
while all δ-electrons are produced and transported by G4DNA. A customized
physics list, G4EmPen+IonGas, which is based on G4EmPen and the models
describing the ionization of gas media by ions, is also used in calculations.
2.2.2 Hadronic physics
A customized physics list was implemented for the description of hadronic pro-
cesses. The first fast stage of nucleus-nucleus collisions is described by two
Geant4 models, the Light Ion Binary Cascade model (G4BIC) [24] for pro-
ton, helium and lithium beams, and the Quantum Molecular Dynamics model
(G4QMD) [25] for carbon beams. As a result of simulation of a nucleus-nucleus
collision some excited nuclear fragments are produced in addition to free nu-
cleons. Therefore, the G4ExcitationHandler of Geant4 is used to simulate sub-
sequent decays of excited nuclear fragments by applying various de-excitation
models depending on the mass and excitation energy of these fragments. The
Fermi break-up model (G4FermiBreakUp) is applied to excited nuclei lighter
than fluorine. It is designed to describe explosive disintegration of excited
light nuclei [26] and it is highly relevant to collisions of light nuclei with nu-
clei of tissue-like materials. For heavier excited nuclei either the evaporation
model [27] can be used at low excitations (below 3 MeV per nucleon), or the
statistical multifragmentation model (SMM) [26] at higher excitation energies.
Generally, the inclusion of fragmentation reactions helps to describe the yield
of intermediate-mass fragments.
2.3 Theoretical estimation of RBE
The RBE for a given kind of mammalian cells irradiated by ions can be estimated
using the microdosimetric-kinetic (MK) model [28, 29]. The MK model com-
bines a microdosimetric description of energy deposition events in sub-nuclear
domains of irradiated cells with a kinetic description of creation and repair of
radiation-induced lesions. In this phenomenological model the linear-quadratic
relation for the cell survival curve is derived for low-LET radiation by assuming
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a Poisson distribution of lethal lesions in the domain volume [30]. In the case
of high-LET particles a non-Poisson distribution is applied as a correction for
the overkill effect [29]. An alternative approach was also proposed [20], which
exploits the dose-mean lineal energy corrected for saturation. This modified
version of the MK model [20] allows to use microdosimetric spectra measured
by TEPCs to estimate survival rates of irradiated cells.
In particular, the surviving fraction S of human salivary gland (HSG) tumour
cells is expressed as exponent of a linear-quadratic function of the dose D,
S = exp
[
−αD − βD2
]
, (4)
where
α = α0 +
β
ρπr2d
y∗ , (5)
with the following model parameters: α0 = 0.13 Gy
−1 as a constant that rep-
resents the initial slope of the survival fraction curve in the limit of zero LET,
β = 0.05 Gy−2 as a constant independent of LET, ρ =1 g/cm3 as the density
of tissue and rd =0.42 µm as the radius of a sub-cellular domain in the MK
model. Equation (5) establishes a relation between y∗ and the α-parameter of
the linear-quadratic model irrespective of the specific ion species. This relation
reflects the fact that an excessive local energy deposition is inefficient to boost
a given biological effect [19]. This leads to a reduction of the RBE known as
the saturation effect.
According to the modified MK model the RBE for HSG cells can be esti-
mated using the following relation [31]:
RBE10 =
2βD10,R√
α2 − 4β ln (0.1)− α
, (6)
where D10,R = 5.0 Gy is the 10% survival dose of the reference radiation
(200 kVp X-rays) for HSG cells [20].
As shown in [20, 32], the microdosimetric parameter y∗ is well suited to
estimate the α-parameter for HSG and other cell lines for a large variety of
projectiles including proton, helium and carbon nuclei. Therefore, the RBE
values for various therapeutic beams can be obtained from the corresponding
microdosimetry spectra. In the present study the aforementioned modified MK
model is used to estimate the RBE of proton, 4He, 7Li and 12C beams for HSG
cells. Firstly, microdosimetric spectra are calculated by means of the MCHIT
model placing the walled TEPC described above behind a range shifter made
of water. The thickness of the range shifter was varied in order to calculate
the microdosimetry spectra at different water-equivalent depths. The pressure
of the TE gas was set to simulate a tissue sphere of 1 µm in diameter and the
detector was irradiated by a broad beam. This set-up mimics the experimental
conditions used by Kase et al. in measurements of y∗ for a 290A MeV 12C
beam [20]. RBE10 values for HSG cells irradiated by carbon beams were esti-
mated according to Eq. (6) with the experimental and simulated values of y∗
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and used for the MCHIT validation. RBE10 for proton, helium and lithium were
also calculated for the sake of comparison. In order to evaluate the biological
effectiveness away from the beam axis, a second set-up was devised. In this case
the TEPC was placed inside a water phantom at depths close to the Bragg peak
and 2 cm away from the axis of a pencil-like beam. A large number (∼ 107) of
beam particle histories were simulated to ensure that statistical fluctuations of
the calculated y∗ are negligible in all set-up configurations.
3 Results and Discussion
3.1 Contribution of secondary fragments to the micro-
dosimetry spectra
The role of nuclear reactions to attenuate the intensity of 1H, 4He, 7Li and 12C
beam particles while they propagate in water can be well understood from Fig. 3.
The energy per projectile nucleon was taken as 152.6 MeV for 1H, 152 MeV for
4He, 176 MeV for 7Li and 290 MeV for 12C. With this choice of energies all the
beams have the Bragg peaks at 161.6 mm depth in water. In Fig. 3 the fractions
of surviving beam nuclei at certain depth (bottom) are plotted together with the
corresponding depth-dose curves (top). As seen from Fig. 3, ∼ 50% of 7Li and
12C beam nuclei are lost before they reach the depth of the Bragg peak, where
they finally stop. Nuclear reactions are less frequent for 1H and 4He beams, as
only ∼ 20% of protons and ∼ 30% of alphas participate in nuclear reactions
before they stop.
In the experiments of Tsuda et al. [21] the 1H and 4He projectiles entered
the TEPC after traversing 150–170 mm of water when their energies were re-
duced to 17–38 MeV per nucleon. As seen from Fig. 3, this corresponds to a
TEPC placed close to the Bragg peak. Even at this deep location ∼ 70–80% of
beam protons and alphas reached the TEPC without participating in nuclear
reactions. Therefore, a relatively small contribution of secondary fragments to
microdosimetry spectra is expected for 1H and 4He beams. Nevertheless, as
demonstrated below, for 4He beam the contributions of specific secondary frag-
ments to microdosimetry spectra can still be identified. The contributions of
secondary fragments to microdosimetry spectra obtained with 7Li and 12C [22]
are expected to be much larger as compared with 1H and 4He beams. Indeed,
as can be estimated from Fig. 3, a noticeable number of secondary fragments
of 7Li and 12C traverse TEPCs placed at the depth of ∼ 50 mm and especially
near the Bragg peak in agreement with the measurements by Martino et al.
The LETs of protons and ions vary significantly in the range of the kinetic
energies used for radiation therapy. The lineal energy y, which is measured
by TEPC, serves as an estimation of LET and its frequency distribution in-
cludes contributions from various particles traversing the detector. However,
since different particles may contribute to similar or overlapping domains of y,
such contributions can not be easily disentangled in experiment [33], unless a
complicated procedure to identify the charges of fragments is involved. Alterna-
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Figure 3: Calculated depth-dose distributions in water for 1H, 4He, 7Li and 12C
beams considered in the present work (top panel) and the attenuation factor for
these beams due to nuclear reactions (bottom panel).
tively, specific contributions from certain particles can be scored and identified
in calculations using the Monte Carlo method. Once the validity of Monte Carlo
modelling is confirmed by a good agreement of calculated and measured spec-
trum, the contributions from specific particles can be reliably identified. The
study of microdosimetry spectra collected far from the beam helps to evaluate
the accuracy of nuclear fragmentation models since such spectra are built en-
tirely by secondary fragments. At the same time, the Monte Carlo modelling
of microdosimetry spectra opens the possibility to understand the quality of
radiation in mixed radiation fields.
3.2 Beam of 1H in water
The simulated microdosimetry spectrum for a proton beam traversing a 163 mm
range shifter made of water is shown in Fig. 4 along with experimental data [21].
This spectrum corresponds to the TEPC position at ∼ 13 mm before the Bragg
peak. Similar results, but for a TEPC placed closer to the Bragg peak are shown
in Fig. 5. In the latter case the TEPC is traversed by less energetic protons
which have a higher LET. This is confirmed by the shift of the maximum of
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the microdosimetry spectra to larger y, which can be seen by comparing Fig. 5
and Fig. 4. One can clearly see that the model systematically underestimates
m)µ (keV/y
-110 1 10 210
fy
y 
f(y
)/
-410
-310
-210
-110
1
wl-TEPC behind
a range shifter
of 163 mm-we
H 160 MeV1
exp. data
G4EmPen
Figure 4: Microdosimetry spectrum
calculated with G4EmPen behind the
range shifter (163 mm w.e.) for a 160
MeV proton beam. Circles represent
experimental data [21] corresponding to
the estimated average proton energy of
38 MeV at the entrance to TEPC.
m)µ (keV/y
-110 1 10 210
fy
y 
f(y
)/
-410
-310
-210
-110
1
wl-TEPC behind
a range shifter
of 173.5 mm-we
H 160 MeV1
exp. data
G4EmStd
G4EmPen
G4DNA
Figure 5: Microdosimetry spectra
calculated with G4EmPen, G4EmStd
and G4DNA behind the range shifter
(173.5 mm w.e.) for a 160 MeV pro-
ton beam. Circles represent experimen-
tal data [21] corresponding to the esti-
mated average proton energy of 20 MeV
at the entrance to TEPC.
events with very low lineal energy (y < 1 keV/µm) in all simulations with the
wall-less TEPC. In order to investigate whether this is related to the limita-
tion for production of δ-electrons with G4EmStd and G4EmPen, we carried out
a simulation with G4DNA with results presented in Fig. 5. The distribution
of particle energies downstream of the TEPC window was first calculated with
G4EmPen and then used as an input to simulations with G4DNA. The simulated
gas cavity of the TEPC was replaced in G4DNA simulations by a homogeneous
water-equivalent volume. As shown in Fig. 5, G4EmPen and G4DNA provide
statistically equivalent results even though the simulation with G4EmPen ac-
counts for a detailed geometric description of the detector, while G4DNA works
only with an equivalent cylindrical water volume. Since there are no low-energy
limits for production of δ-electrons in simulations with G4DNA, one should con-
clude that the deficit of events with very low y is not related to limitations of
electron transport.
As seen from Fig. 5, the microdosimetric spectrum of protons calculated
for the macroscopic-size TEPC agree well with the microdosimetric spectrum
calculated for the equivalent microscopic volume of water with the G4DNA
physics list. This confirms the basic assumption of the microdosimetry technique
and justifies the calculation of microdosimetric spectra using the continuous
slowing-down approximation.
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3.3 Beam of 4He in water
Microdosimetry spectra calculated for helium beams with three physics lists,
namely G4EmStd, G4EmPen and G4EmPen+IonGas are presented in Fig. 6.
G4EmStd and G4EmPen give statistically equivalent results which, however,
both slightly deviate from the experimental spectrum [21] at low y and also
close to the maximum. Once the models for the gas ionization are involved
in calculations in the G4EmPen+IonGas physics list, the agreement with the
measured spectrum for y >1 keV/µm is improved, in particular, close to its
maximum. The shape of microdosimetry spectra for helium beams differs from
m)µ (keV/y
-110 1 10 210
fy
y 
f(y
)/
-410
-310
-210
-110
1
He 150 MeV/u4
exp. data
G4EmStd
G4EmPen
G4EmPen+IonGas
wl-TEPC behind
a range shifter
of 157.1 mm-we
Figure 6: Microdosimetry spectrum be-
hind a range shifter (157.1 mm w.e.)
for a 150A MeV 4He beam calcu-
lated with G4EmStd, G4EmPen and
G4EmPen+IonGas. Circles represent
experimental data [21] corresponding to
the estimated average 4He energy of
17A MeV at the entrance to TEPC.
m)µ (keV/y
-110 1 10 210
fy
y 
f(y
)/
-410
-310
-210
-110
1
wl-TEPC behind
a range shifter
of 157.1 mm-we
He 150 MeV/u4
exp. data
G4EmPen+IonGas
He
H
Figure 7: Same as in Fig. 6, but with mi-
crodosimetry spectrum calculated only
with G4EmPen+IonGas. Specific con-
tributions from hydrogen and helium
nuclei are shown separately as explained
in the figure legend.
the one for proton beams. Two distinct peaks are observed in the spectra for
4He nuclei. As can be seen from the decomposition of the calculated spectra
into contributions of hydrogen and helium nuclei shown in Fig. 7, these two
prominent peaks are due to hydrogen fragments for events with low y and due
to helium nuclei for events with high y. A certain evolution of the position
of the helium peak can be observed in Figs. 7, 8 and 9 as the energy per
nucleon of 4He increases. While the projectile energy increases, the helium
peak shifts to lower y. At the same time there are no noticeable changes in the
peak position of hydrogen fragments. This can be explained by the fact that
produced hydrogen fragments have an energy spectrum which depends weakly
on the beam energy. One can see that the yields of events with y < 1 keV/µm
in the spectra for the 4He beam are underestimated by the MCHIT model, but
the reason for this effect may be different as compared to the case of 1H beam.
The events with y < 1 keV/µm in the spectra calculated for the 4He beam
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are mainly due to secondary hydrogen fragments, see Figs. 7, 8 and 9, and
secondary electrons (not shown). This means that the observed effect could
also be related to an inaccuracy of the Light Ion Binary Cascade model used to
simulate the fragmentation of the 4He beam.
m)µ (keV/y
-110 1 10 210
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f(y
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-310
-210
-110
1
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of 155.3 mm-we
He 150 MeV/u4
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Figure 8: Microdosimetry spectrum be-
hind a range shifter (155.3 mm w.e.)
for a 150A MeV helium beam. Spe-
cific contributions from hydrogen and
helium nuclei are shown separately as
explained in the figure legend. Circles
represent experimental data [21] corre-
sponding to the estimated average 4He
energy of 22A MeV at the entrance to
TEPC.
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Figure 9: The same as Fig. 8 but for
a 151.3 mm w.e. range shifter. Circles
represent experimental data [21] corre-
sponding to the estimated average 4He
energy of 32A MeV at the entrance to
TEPC.
3.4 Beam of 7Li in water
Calculated and measured [22] microdosimetry spectra for lithium beams at nine
positions inside a water phantom are shown in Fig. 10. The centre of the TEPC
was placed at three positions at the depth of 58.8, 185.8 and 283.8 mm (centers of
the gas chamber) corresponding to the plateau, Bragg peak and tail of the depth-
dose distribution on the beam axis and also at 2 and 10 cm radial distance from
the axis. The microdosimetry spectra on the beam axis typically characterize
the radiation field in the center or in front of the target tumour volume during
ion therapy.
In addition to the total spectra the contributions from specific nuclei, H, He
or Li, are also shown. Prominent peaks of primary 7Li nuclei at y = 5 keV/µm
and y = 50 keV/µm are seen in the yd(y) distributions calculated on the beam
axis at the plateau and Bragg peak, respectively. These peaks are expected
to provide the major therapeutic effect. They are superimposed on broader
contributions from hydrogen and helium fragments located before and after
the main 7Li peak. All events registered at the Bragg peak position due to
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secondary nuclei are characterized by lower y compared to the events due to 7Li
nuclei. This relation between y of beam nuclei and their fragments also holds
at the “0 cm, plateau” position. However, in the latter case there exists also a
contribution of He nuclei produced in the fragmentation of target nuclei. Since
such fragments are slower compared to 7Li projectiles and their fragments, such
target fragments are responsible for events with high y values, which are seen
right to the main peak in the first panel of Fig. 10.
The shapes and positions of the calculated and measured 7Li peaks essen-
tially differ at “0 cm, plateau”. The calculated peak is sharper as compared to
the data and centred at smaller y. The y¯d calculated with MCHIT equals to
7.32 keV/µm, which is smaller than the value 13.6 keV/µm estimated from the
measured spectrum. In addition, the average number of events per beam parti-
cle in the TEPC placed at “0 cm, plateau” is calculated by MCHIT as N¯c = 0.94
due to a slight attenuation of the beam after its entrance to the water phantom.
According to the normalization of the measured spectra the average number of
TEPC events per beam particle in the experiment is only N¯e = 0.48. All these
observations led us to the conclusion that some of the high-y events detected at
“0 cm, plateau” were due to two or more 7Li nuclei traversing the TEPC within
a short time interval and thus appeared as a single event. Such pile-up events are
characterized by an elevated energy deposition to the detector. Since all beam
particle histories are modelled by MCHIT independently of each other, pile-up
events are impossible in the present simulation. Therefore, providing that the
difference between N¯c and N¯e is only due to the pile-up effect, the probability
of an event induced by multiple 7Li at “0 cm, plateau” can be estimated as
Pmult =
N¯c − N¯e
N¯c
= 0.49 . (7)
One can define the pile-up probability Ppu as a probability of a single TEPC
event induced by a pair of 7Li nuclei. Since multiple events are represented by
double, triple etc. coincidence events,
Pmult = Ppu + P
2
pu + P
3
pu + . . . =
1
1− Ppu
− 1 =
Ppu
1− Ppu
, (8)
resulting in
Ppu =
Pmult
1 + Pmult
= 0.33 . (9)
In order to estimate the contribution of pile-up events to microdosimetry spectra
a Monte Carlo method was implemented. The f(y) distribution calculated by
MCHIT at “0 cm, plateau” was used to sample independent y events. For each
event, the sampled y value is piled-up with the y value of the previous event
with a probability Ppu. The resulting yd(y) distribution is shown in Fig. 10
labelled as “Tot + pile-up”. As seen, the accounting for pile-up events restores
the agreement between calculated and experimental yd(y) distributions.
Beam nuclei do not reach TEPC at “0 cm, tail” and other six positions, where
the spectra are build mainly by secondary H and He fragments and δ-electrons.
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Figure 10: Microdosimetry spectra in water phantom irradiated by 185A MeV
7Li nuclei calculated with MCHIT using G4BIC and G4EmPen+IonGas. Con-
tributions from nuclear fragments of a given charge are shown by various lines
as explained in the legend. The distribution at “0 cm, plateau” labelled as
“Tot + pile-up” was obtained with accounting for pile-up events. Circles repre-
sent experimental data [22].
Also target fragments may eventually contribute with large y events as can be
seen at “10 cm, tail” but one should keep in mind the poor statistic for such
events for TEPC positions at 10 cm away from beam axis. The general shapes
of calculated microdosimetry spectra are found to be similar to the shapes of
measured spectra. However, the spectra at the tail, 2 and 10 cm away from the
beam axis are underestimated by MCHIT. Since at all these positions (excluding
“2 cm, peak”) the spectra are mostly formed by hydrogen-like fragments, this
indicates that the yields of proton, deuterons and tritons may be underestimated
by the Light Ion Binary Cascade model used to simulate fragmentation of 7Li
projectiles. For the TEPC position “2 cm, peak” this deficiency may also be
connected to some underestimation of the yield of helium fragments, as the
cascade model neglects the cluster structure of 7Li and treats all intra-nuclear
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nucleons as uncorrelated. It is expected that accounting for the cluster structure
of light nuclei would enhance the emission of alpha particles.
3.5 Beam of 12C in water
Calculated and measured [22] microdosimetry spectra for carbon beams at nine
positions inside a water phantom are shown in Fig. 11. The exact TEPC po-
sitions used in simulations are given in our previous publication [18], where
further details on the calculational procedure can be found. A shoulder in the
spectrum at low y at “0 cm, plateau” position is due to the contribution of sev-
eral projectile fragments. Similar to 7Li beam, the events with y>100 keV/µm
are due to protons and alphas emitted by target nuclei. Since these target
fragments are much slower than the projectile fragments, they provide higher y
values at this TEPC position with respect to a sharp peak due to primary 12C
nuclei. Apart from the underestimation of events with 40< y <100 keV/µm,
the spectrum measured at the entry to the water phantom on the beam axis
is well reproduced by MCHIT. The peak of primary 12C nuclei also dominates
at the TEPC position “0 cm, peak” on the beam axis close to the Bragg peak.
There, the agreement with the measured spectrum is in general good with the
exception of a slight underestimation of the contribution of projectile fragments
seen at lower y before the main peak.
The spectra at “0 cm, tail”, “2 cm, peak” and “2 cm, tail” are built from
overlapping contributions from various projectile fragments: H, He, Li and Be.
Among these three positions a noticeable contribution from boron nuclei is pre-
dicted only at “2 cm, peak”. As follows from the calculations, the maxima of
the contributions from H, He, Li, Be and B are ordered according to Z2 of
the corresponding nuclei: more heavy fragments contribute with larger y. The
contributions from He nuclei are remarkable. The spectra at these three po-
sitions are also underestimated, as in the case of 7Li beam. The quantitative
agreement between calculations and measurements for 12C beam is much better
compared to 7Li beam, but still the deviations of the calculated spectra from
measured ones can be attributed to the underestimation of He fragments. The
other four spectra, namely, at “2 cm, plateau”, “10 cm, plateau”, “10 cm, peak”
and “10 cm, tail” are mostly composed from the contributions of hydrogen nu-
clei produced in fragmentation of 12C. They are also slightly underestimated by
MCHIT. Some traces of the contributions from fragments of the target nuclei
are also seen at these four positions far from the 12C beam. Such target frag-
ments are scarcely produced in nuclear reactions induced by energetic secondary
protons and neutrons.
3.6 RBE and biological dose profiles for 1H, 4He, 7Li and
12C beams
Using the calculated microdosimetry spectra we may now estimate the biological
effectiveness of 1H, 4He, 7Li and 12C nuclei. For the sake of comparison we have
chosen their beam energies such that they lead to similar ranges in water. The
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Figure 11: Microdosimetry spectra in water phantom irradiated by 300A MeV
12C nuclei calculated with MCHIT using G4QMD and G4EmPen+IonGas. Con-
tributions from nuclear fragments of a given charge are shown by various lines
as explained in the legend. Circles represent experimental data [22].
microdosimetry spectra were calculated at several positions along the beams
axes. The corresponding energy deposition profiles (bin size of 0.1 mm) are
shown in logarithmic and linear scales in the top panels of Figs. 3 and 12,
respectively.
As demonstrated in the previous sections, the microdosimetric spectra de-
pend strongly on depth and radial distance from the beam axis. Such variation
in the energy deposition pattern leads to very different biological effects. The
values of RBE10 estimated by means of MCHIT coupled with the modified MK
model on the beam axis as a function of depth are presented in the middle
panel of Fig. 12 for the four ion beams. Experimental RBE10 for carbon beam
estimated from experimental data [20] are plotted in the same figure for com-
parison. The well-known increase of the RBE for carbon ions on their way
from the plateau region to the Bragg peak seen in the experimental data is
well reproduced by MCHIT+MK model. Helium and lithium ions also show
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Figure 12: Calculated energy deposition profile per ion beam in water for 1H,
4He, 7Li and 12C beams with Bragg peak at 161.6 mm (top panel), estimated
RBE10 for HSG cells (middle panel) and biological dose (bottom panel). The
cross symbols (✚) show the RBE10 calculated from experimental values of
y∗ [20] while other symbols present calculated results by MCHIT with mod-
ified MK model. The biological doses for all ions were rescaled by respective
values at the Bragg peak.
favourable RBE profiles characterized by even lower values at the plateau re-
gion, with much steeper increase close to the Bragg peak and lower RBE values
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in the tail. The maximum RBE10 values for helium, lithium and carbon ions
found around the Bragg peak are 2.2, 2.5 and 2.9, respectively. At the plateau
region the values are 1.0, 1.0 and 1.2, respectively. For protons, the model pre-
dicts the RBE10 value slightly below 1 at the entrance to the phantom and a
smooth increase to 1.2 at the Bragg peak. A further increase of RBE10 after the
peak may be related to slow secondary neutrons produced in nuclear reactions.
Similar calculations were performed with the TEPC placed 2 cm away from the
beam axis at the depth of the Bragg peak. At this point RBE10 of 1.1±0.1 was
estimated from calculated microdosimetry spectra for all four ions.
The biological dose at the considered TEPC positions can now be estimated
as the product of RBE and the physical dose. The results for the biological dose
for different ions are shown in the bottom panel of Fig. 12. The curves were
rescaled in order to yield the same dose at the Bragg peak. The biological dose
profiles for the helium, lithium and carbon beams were found to be similar to
each other. All three ions demonstrate a high ratio of the dose at the Bragg
peak relative to the dose at the plateau which helps to spare healthy tissues
traversed by the beam before reaching a tumour. The biological dose values at
the tail of the lithium and carbon beams are found to be very similar, while
the helium beam delivers a smaller dose to the tail region due to a reduced
fragmentation rate. These results show that helium and lithium beams are also
promising options in addition to a well-established carbon-ion cancer therapy.
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Figure 13: Calculated correlation between RBE10 and y¯f for
1H, 4He, 7Li and
12C beams in water. The lines connect the values obtained for TEPCs se-
quentially placed along the beam axes while arrows indicate the direction for
increasing depth. Full symbols indicated by letters ‘a’, ‘b’, ‘c’ and ‘d’ correspond
to the values at the Bragg peak for protons, helium, lithium and carbon ions,
respectively.
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Despite the fact that the depth-dose and RBE10 profiles shown in Fig. 12
look similar in shape, the relation between y¯f representing LET and RBE10 is
not trivial. The correlated pairs of values y¯f and RBE10 are shown in Fig. 13
for all four considered beams. The curves demonstrate a monotonic increase
of RBE10 with the rise of y¯f before the Bragg peak. The correlations for
4He
and 7Li are similar to each other, but they differ from the case of 12C. In the
case of the carbon beam, the increase is more pronounced but RBE10 reaches
a maximum at the Bragg peak and then slightly drops for increasing y¯f values.
This behaviour shows a kind of saturation effect. Such effect is not observed for
4He and 7Li. Particularly, one can see that for these two ions RBE10 continues
to rise even when y¯f values start decreasing in the tail region. Another feature
of the relation between y¯f and RBE10 is that for a given beam similar y¯f values
correspond to quite different RBE10 at the plateau and tail of the depth-dose
distribution. Primary beam particles and secondary fragments which dominate,
respectively, in these two regions provide rather similar y¯f , but their RBE10
differ significantly. These results confirm that y¯f (LET) solely is not sufficient
to characterize the biological effects of various beams.
4 Conclusion
Our analysis of the microdosimetry spectra for light nuclei lead us to the fol-
lowing conclusions:
• The microdosimetry spectra of protons calculated for the macroscopic-size
TEPC filled with dilute gas agree well with the microdosimetry spectra
calculated for the equivalent microscopic volume of water with G4DNA
physics list. In this way the basic assumption of the microdosimetry tech-
nique is fully validated by Monte Carlo simulations with MCHIT.
• Contributions of primary beam nuclei and secondary fragments to the mi-
crodosimetry spectra can be realistically evaluated by Monte Carlo simu-
lations with MCHIT.
• A proper modelling of nuclear fragmentation reactions is crucial for de-
scribing microdosimetry spectra both on the beam axis and far from the
beam. Further improvements of nuclear fragmentation models, e.g. with
respect to production of 4He nuclei, could improve the description of the
microdosimetry data and, therefore, provide a better understanding of the
radiation effects from the considered therapeutic beams.
• The MCHIT model is able to describe reasonably well the microdosime-
try spectra for hydrogen and helium beams in water. Microdosimetry
spectra for lithium beams are well described on the beam axis from the
entrance down to the Bragg peak while the spectra are underestimated far
from the primary beam. It was demonstrated that in the case of TEPC
directly irradiated by a 7Li beam, the agreement with the experimental
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data can be significantly improved by taking into account the pile-up ef-
fect. This is specific to the experimental data of [22]. It is expected that
similar measurements, but with lower beam current, will be not distorted
by overlapping events. The spectra for carbon beam are generally well de-
scribed, despite of some underestimations at positions far from the beam
axis and also in the tail region.
• MCHIT coupled with the modified MK model allowed us to estimate the
RBE for proton, helium, lithium and carbon ions at several positions in
a water phantom. The models predict favourable biological dose-depth
profiles for helium and lithium beams similar to the one for carbon beam.
This result suggests that helium and lithium beams could also be used for
cancer therapy.
• The correlations between RBE10 and y¯f for proton, helium, lithium and
carbon ions were studied along the beam axis. Such a correlation for
carbon beam reveals the saturation effect. It is found that y¯f (representing
LET) may be similar at the plateau and tail regions, but still lead to very
different biological effects.
• Finally we want to emphasize that the main conclusion of this work is that
helium and lithium beams should be considered as rather favourable op-
tions for cancer therapy. They have reduced fragmentation cross sections
compared to the 12C beam that makes them preferable for a deeply-seated
tumour. On the other hand, they have a reduced lateral scattering com-
pared to the proton beam. At the same time the biological effectiveness
of these beams is only slightly lower than that of 12C beam.
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